HP7: (2S,3S,4R,5R,6R)-5-acetamido-6-[[[(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-3,4-dihydroxy-oxane-2-carboxylic acid
HP7 is a Ligand Of Interest in 3OA0 designated by the RCSB
| Best-fitted instance in this entry |
| Other instances in this entry |
| Best-fitted instance in this entry |
| Best-fitted PDB instances with different target (top 5) |
| Identifier | Ranking for goodness of fit | Ranking for geometry | Real space R factor | Real space correlation coefficient | RMSZ-bond-length | RMSZ-bond-angle | Outliers of bond length | Outliers of bond angle | Atomic clashes | Stereochemical errors | Model completeness | Average occupancy |
|---|
| 3OA0_HP7_C_312 | 88% | 32% | 0.08 | 0.957 | 1.04 | 1.74 | 4 | 13 | 2 | 0 | 100% | 1 |
| 3OA0_HP7_D_312 | 74% | 31% | 0.11 | 0.941 | 0.91 | 1.92 | 1 | 14 | 3 | 0 | 100% | 1 |
| 3OA0_HP7_B_312 | 46% | 33% | 0.153 | 0.89 | 0.99 | 1.75 | 3 | 16 | 3 | 0 | 100% | 1 |
| 3OA0_HP7_A_312 | 30% | 35% | 0.175 | 0.838 | 1.03 | 1.63 | 2 | 11 | 6 | 0 | 100% | 1 |
| 3Q2K_HP7_N_550 | 90% | 27% | 0.089 | 0.971 | 0.93 | 2.13 | 1 | 15 | 1 | 0 | 100% | 1 |
| 3Q2I_HP7_A_550 | 72% | 32% | 0.113 | 0.936 | 1.04 | 1.75 | 3 | 11 | 0 | 0 | 100% | 1 |
